Siren Socks utilize continuous foot temperature monitoring to detect early signs of inflammation, significantly reducing the risk of diabetic foot ulcers. By alerting healthcare providers to potential injuries, the technology aims to prevent complications that can lead to amputation in patients with diabetes.
Funding
$40.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+5Founders
Product
Problem
Diabetic patients face a high risk of developing foot ulcers, which can lead to amputation. Early detection of inflammation, a precursor to ulcers, is critical but often challenging for patients to monitor independently.
Solution
Siren Socks offer a proactive solution by continuously monitoring foot temperature, a key indicator of inflammation and potential injury. The socks transmit data to a nursing team who analyze the information and proactively contact patients to discuss any concerning trends. Healthcare providers receive alerts regarding potential injuries, enabling timely intervention and potentially preventing the development of foot ulcers. The system aims to reduce the risk of complications and improve outcomes for diabetic patients.
Target Audience
The primary target audience includes diabetic patients at risk of developing foot ulcers, as well as podiatrists, endocrinologists, and other healthcare providers managing diabetic foot care.
Features
- Continuous foot temperature monitoring via sensors embedded in the sock fabric.
- Data transmission to a secure platform for analysis.
- Remote monitoring by licensed nurses who proactively contact patients.
- Alerts to healthcare providers regarding potential foot injuries.
- Machine washable socks that are automatically replaced when worn.
- No charging required.
- Medicare coverage.